Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B in Turkey

World Journal of Gastroenterology

Volumn 11, Issue 13, 2005, Pages 1976-1980

  Sunbul, Mustafa ^a   Leblebicioglu, Hakan ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Chronic hepatitis B; Genotype; Interferon 2a

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT ALPHA2A INTERFERON; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONHUMAN; PERCUTANEOUS BIOPSY; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN EUROPE; STATISTICAL ANALYSIS; TURKEY (REPUBLIC); VIRUS DETECTION; VIRUS TYPING;

EID: 17144404610     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i13.1976     Document Type: Article

References (30)

1. Mbayed VA, Lopez JL, Telenta PF, Palacios G, Badia I, Ferro A, Galoppo C, Campos R. Distribution of hepatitis B virus genotypes in two different pediatric populations from Argentina. J Clin Microbiol 1998; 36: 3362-3365
2. Chu CJ, Lok ASF. Clinical significant of hepatitis B virus genotypes. Hepatology 2002; 35: 1274-1276
3. Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology 2001; 34: 590-594
4. Conjeevaram HS, Lok ASF. Management of chronic hepatitis B. J Hepatol 2003; 38: S90-S103
5. Chin R, Locarnini S. Treatment of chronic hepatitis B: current challenges and future directions. Rev Med Virol 2003; 13 255-272
6. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003; 362: 2089-2094
7. Lindh M, Gonzalez JE, Norkrans G, Horal P. Genotyping of hepatitis B virus by restriction pattern analysis of a pre-S amplicon. J Virol Methods 1998; 72: 163-174
8. Esteban R. Management of chronic hepatitis B: an overview. Semin Liver Dis 2002; 22(Suppl 1): 1-6
9. Yuen MF, Lai CL. Treatment of chronic hepatitis B. Lancet Infect Dis 2001; 1: 232-241
10. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 1999; 179: 775-782
11. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 2000; 33: 998-1002
12. Wai CT, Chu JH, Hussain M, Lok ASF. HBV Genotype B is associated with better response to interferon therapy in HBeAg (+) chronic hepatitis than genotype C. Hepatology 2002; 36: 1425-1430
13. Leblebicioglu H, Eroglu C. Acute hepatitis B virus infection in Turkey: Epidemiology and genotype distribution. Clin Microbiol Infect 2004; 10: 537-541
14. Yalcin K, Degertekin H, Bahcecioglu IH, Demir A, Aladag M, Yildirim B, Horasanli S, Ciftci S, Badur S. Hepatitis B virus genotype D prevails in patients with persistently elevated or normal ALT levels in Turkey. Infection 2004; 32: 24-29
15. Thomas H, Foster G, Platis D. Mechanisms of action of interferon and nucleotide analogues. J Hepatol 2003; 39: S93-S98
16. Craxi A, Di Bona D, Camma C. Interferon-a for HBeAg-positive chronic hepatitis B. J Hepatol 2003; 39: S99-S105
17. Trepo C, Maynard M, Zoulim F. Perspectives on therapy of hepatitis B. J Hepatol 2003; 39: S220-S223
18. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 11; 337: 1733-1745
19. Yuen MF, Lai CL. Current and future antiviral agents for chronic hepatitis B. J Antimicrob Chemother 2003; 51: 481-485
20. Hoofnagle JH. Challenges in therapy of chronic hepatitis B. J Hepatol 2003: S230-S235
21. Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002; 122: 1756-1762
22. Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection. J Clin Microbiol 2002; 40: 1207-1209
23. Zhang X, Zoulim F, Habersetzer F, Xiong S, Trepo C. Analysis of hepatitis B virus genotypes and pre-core region variability during interferon treatment of HBe antigen negative chronic hepatitis B. J Med Virol 1996; 48: 8-16
24. Schalm SW, Thomas HC, Hadziyannis SJ. Chronic hepatitis B. Prog Liver Dis 1990; 9: 443-462
25. Lok ASF. Hepatitis B infection: pathogenesis and management. J Hepatol 2000; 32(Suppl 1): 89-97
26. Rizzetto M, Volpes R, Smedile A. Response of precore mutant chronic hepatitis B infection to lamivudine. J Med Virol 2000; 61: 398-402
27. Sunbul M, Leblebicioglu H, Koksal I, Aygen B, Akbulut A, Hosoglu S, Dokmetas I, Ulusoy S. The response to interferon therapy of hepatitis B infections caused by precore. Viral Hepatit Dergisi 2001; 2: 286-289
28. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variation in the primary structure of the surface antigen. J Gen Virol 1993; 74 1341-1348
29. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 1997; 175: 1285-1293
30. Trevisani F, D'Intino PE, Grazi GL, Caraceni P, Gasbarrini A, Colantoni A, Stefanini GF, Mazziotti A, Gozzetti G, Gasbarrini G, Bernardi M. Clinical and pathologic features of hepatocellular carcinoma in young and older Italian patients. Cancer 1996; 77: 2223-2232